Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

762 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Occult hepatitis B virus infection in HIV-infected patients with isolated antibodies to hepatitis B core antigen: Aquitaine cohort, 2002-2003.
Neau D, Winnock M, Jouvencel AC, Faure M, Castéra L, Legrand E, Lacoste D, Ragnaud JM, Dupon M, Fleury H, Lafon ME, Dabis F; Groupe d'Epidemiologie Clinique du SIDA en Aquitaine. Neau D, et al. Among authors: faure m. Clin Infect Dis. 2005 Mar 1;40(5):750-3. doi: 10.1086/427882. Epub 2005 Jan 28. Clin Infect Dis. 2005. PMID: 15714424
Domain structure in a superconducting ferromagnet.
Fauré M, Buzdin AI. Fauré M, et al. Phys Rev Lett. 2005 May 13;94(18):187202. doi: 10.1103/PhysRevLett.94.187202. Epub 2005 May 11. Phys Rev Lett. 2005. PMID: 15904406
Socioeconomic Deprivation Weighs Heavily on Liver Fibrosis and Mortality After Hepatitis C Cure (ANRS CO22 Hepather).
Barré T, Parlati L, Bourlière M, Ramier C, Marcellin F, Protopopescu C, Di Beo V, Moins C, Dorival C, Nicol J, Zucman-Rossi J, Mathurin P, Larrey D, Boursier J, Carrat F, Carrieri P; ANRS/AFEF Hepather Study group. Barré T, et al. J Viral Hepat. 2024 Dec;31(12):830-846. doi: 10.1111/jvh.14006. Epub 2024 Sep 10. J Viral Hepat. 2024. PMID: 39252600
Safety of immune checkpoint inhibitor rechallenge after severe immune-related adverse events: a retrospective analysis.
Eldani C, Kostine M, Faure M, Lazaro E, Rigothier C, Hiriart JB, Teulières B, Poullenot F, Haissaguerre M, Zysman M, Veillon R, Vergnenegre C, Issa N, Domblides C, Mary-Prey S, Beylot-Barry M, Pham-Ledard A, Dutriaux C, Sole G, Duval F, Gerard E. Eldani C, et al. Among authors: faure m. Front Oncol. 2024 Jul 8;14:1403658. doi: 10.3389/fonc.2024.1403658. eCollection 2024. Front Oncol. 2024. PMID: 39040444 Free PMC article.
762 results